abiraterone has been researched along with Chromosomal Instability in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Anand, M; Antonarakis, ES; Armstrong, AJ; Barnett, ES; Berry, WR; Brown, LC; Carbone, EA; Danila, DC; George, DJ; Giannakakou, P; Gill, A; Gregory, SG; Gupta, S; Halabi, S; Healy, P; Jendrisak, A; Luo, J; Nanus, DM; Scher, HI; Schonhoft, JD; Szmulewitz, RZ; Wenstrup, R; Yang, Q; Zhao, JL | 1 |
1 other study(ies) available for abiraterone and Chromosomal Instability
Article | Year |
---|---|
Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide.
Topics: Adult; Aged; Aged, 80 and over; Androstenes; Benzamides; Chromosomal Instability; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Neurosecretory Systems; Nitriles; Phenotype; Phenylthiohydantoin; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome | 2021 |